Search for: "Unit, Inc., Appeal of"
Results 1 - 20
of 13,806
Sort by Relevance
|
Sort by Date
20 Jun 2024, 4:42 pm
On appeal, the U.S. [read post]
20 Jun 2024, 1:29 pm
In United States v. [read post]
20 Jun 2024, 6:25 am
Kaiser Gypsum Company, Inc., et al. [read post]
20 Jun 2024, 6:25 am
Kaiser Gypsum Company, Inc., et al. [read post]
20 Jun 2024, 6:25 am
Kaiser Gypsum Company, Inc., et al. [read post]
18 Jun 2024, 6:00 am
The United States Supreme Court will soon issue its decision on a major case – Relentless Inc. v. [read post]
17 Jun 2024, 11:15 am
Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board (PTAB) panels, Director Review (DR) as a standalone review mechanism was essentially non-existent. [read post]
17 Jun 2024, 11:15 am
Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board (PTAB) panels, Director Review (DR) as a standalone review mechanism was essentially non-existent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 4:16 pm
The Supreme Court allowed the appeal by a majority of three-to-two. [read post]
15 Jun 2024, 7:05 am
The case has been appealed to the US Court of Appeals for the Fourth Circuit five times, and when these attempts failed, CACI sought a review by the Supreme Court that was denied. [read post]
15 Jun 2024, 6:31 am
Kovacs are Directors at Innisfree M&A Inc. [read post]
15 Jun 2024, 6:31 am
Kovacs are Directors at Innisfree M&A Inc. [read post]
14 Jun 2024, 4:21 pm
Appeal from the United States District Court for the Northern District of California. [read post]
14 Jun 2024, 11:25 am
” Citing Amgen Inc. v. [read post]